| 1. |
|
|
| 2. |
- Bales, Chris, et al.
(författare)
-
SHINE Doctoral School : Results from six PhD studies on large scale solar thermal
- 2016
-
Ingår i: 4th International Solar District Heating Conference.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- The Solar Heat Integration NEtwork (SHINE) is a European research school in which 13 PhD students in solar thermal technologies are funded by the EU Marie-Curie program. It has five PhD course modules as well as workshops and seminars dedicated to PhD students both within the project as well as outside of it. The SHINE research activities focus on large solar heating systems and new applications: on district heating, industrial processes and new storage systems. The scope of this paper is on systems for district heating for which there are six PhD students, five at universities and one at a company. The initial work concentrated on literature studies and on setting up initial models and measurement setups to be used for validation purposes. The measurements have been used for validating simulation models, including those used for extending the capabilities of the planning tool Polysun to simulate smaller district heating systems. Some results of these studies are presented in the paper. The PhD students will complete their studies in 2017-18.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Figueira, M., et al.
(författare)
-
ALMA observations of RCW 120 Fragmentation at 0.01 pc scale
- 2018
-
Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 616
-
Tidskriftsartikel (refereegranskat)abstract
- Context. Little is known about how high-mass stars form. Around 30% of the young high-mass stars in the Galaxy are observed at the edges of ionized (H ii) regions. Therefore these are places of choice to study the earliest stages of high-mass star formation, especially toward the most massive condensations. High spatial resolution observations in the millimeter range might reveal how these stars form and how they assemble their mass. Aims. We want to study the fragmentation process down to the 0.01 pc scale in the most massive condensation (1700 M ) observed at the southwestern edge of the H ii region RCW 120 where the most massive Herschel cores (∼124 M in average) could form high-mass stars. Methods. Using ALMA 3 mm continuum observations toward the densest and most massive millimetric condensation (Condensation 1) of RCW 120, we used the getimages and getsources algorithms to extract the sources detected with ALMA and obtained their physical parameters. The fragmentation of the Herschel cores is discussed through their Jeans mass to understand the properties of these future stars. Results. We extracted 18 fragments from the ALMA continuum observation at 3 mm toward eight cores detected with Herschel, whose mass and deconvolved size range from 2 M to 32 M and from 1.6 mpc to 28.8 mpc, respectively. The low degree of fragmentation observed regarding thermal Jeans fragmentation suggests that the observed fragmentation is inconsistent with ideal gravitational fragmentation and other ingredients such as turbulence or magnetic fields should be added to explain this inconsistency. Finally, the range of the mass of the fragments indicates that the densest condensation of RCW 120 is a favorable place for the formation of high-mass stars with the presence of a probable UCH ii region associated with the 27 M Fragment 1 of Core 2.
|
|
| 7. |
|
|
| 8. |
- Verslype, C., et al.
(författare)
-
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
- 2007
-
Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534 .- 1569-8041. ; 18:Suppl. 7, s. VII1-VII10
-
Tidskriftsartikel (refereegranskat)abstract
- This article summarizes the expert discussion on the management of pancreatic cancer, which took place during the 8th World Congress on Gastrointestinal Cancer in June 2006 in Barcelona. A multidisciplinary approach to a patient with pancreatic cancer is essential, in order to guarantee an optimal staging, surgery, selection of the appropriate (neo-)adjuvant strategy and chemotherapeutic choice management. Moreover, optimal symptomatic management requires a dedicated team of health care professionals. Quality control of surgery and pathology is especially important in this disease with a high locoregional failure rate. There is now solid evidence in favour of chemotherapy in both the adjuvant and palliative setting, and gemcitabine combined with erlotinib, capecitabine or platinum compounds seems to be slightly more active than gemcitabine alone in advanced pancreatic cancer. There is a place for chemoradiotherapy in selected patients with locally advanced disease, while the role in the adjuvant setting remains controversial. Those involved in the care for patients with pancreatic cancer should be encouraged to participate in well-designed clinical trials, in order to increase the evidence-based knowledge and to make further progress.
|
|
